Aytu Biopharma (AYTU) Gross Profit Growth (3y) (2017 - 2026)
Aytu Biopharma (AYTU) Gross Profit Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 0.95% |
| 10 | Aytu Biopharma | 21.45 Mn | -5.27 Mn | 7.60 Mn | -15.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.83% |
| Dec 31, 2025 | -17.75% |
| Sep 30, 2025 | -20.13% |
| Jun 30, 2025 | -11.60% |
| Mar 31, 2025 | 0.31% |
| Dec 31, 2024 | -4.28% |
| Sep 30, 2024 | -1.28% |
| Jun 30, 2024 | -0.73% |
| Dec 31, 2023 | 17.96% |
| Sep 30, 2023 | 11.30% |
| Jun 30, 2023 | 24.76% |
| Mar 31, 2023 | 27.44% |
| Dec 31, 2022 | 88.82% |
| Sep 30, 2022 | 156.85% |
| Jun 30, 2022 | 140.52% |
| Mar 31, 2022 | 93.13% |
| Dec 31, 2021 | 113.16% |
| Sep 30, 2021 | 130.22% |
| Jun 30, 2021 | 154.68% |
| Dec 31, 2020 | 137.30% |